iBrick – ALGO BIOTECHNOLOGIES

The development and launch of a new drug is a time-consuming and costly process.

The average clinical development time is increasing togheter with costs.

An answer to these challenges comes from the use of algorithms to predict the innovation and market penetration of new drugs. Do you want to know more? Click the link below and connect with ALGO BIOTECHNOLOGIES.

iBRICK (mailchi.mp)

They envision making the pharma R&D progressively more and more efficient through their disruptive technology